Citations

Clear

1053 citation(s) found for "Andre, F".

M 3 RNA Drives Targeted Gene Delivery in Acute Myocardial Infarction
Singh, Raman Deep , Hillestad, Matthew L. , Livia, Christopher , Alekseev, Alexey E., Witt, Tyra A. , Stalboerger, Paul G., Behfar, Atta , Yamada, Satsuki , Behfar, Atta , Livia, Christopher , Li, Mark, Terzic, André

Mayo Clinic

Tissue Engineering Part A | July 26, 2018 | Volume: 25 | Issue: 1-2 | Pages: 145-158

10.1089/ten.tea.2017.0445 | PMID 30047313 Get It

A comprehensive evaluation of the genetic architecture of sudden cardiac arrest
Ashar, Foram N., Albert, Christine M. , Newton‐Cheh, Christopher , Brody, Jennifer A. , Müller‐Nurasyid, Martina , Moes, Anna, Huikuri, Heikki V. , Junttila, Juhani , Goyette, Philippe, Pazoki, Raha , Tanck, Michael W.T. , Blom, Marieke T. , Jabbari, Reza , Glinge, Charlotte , Tragante, Vinicius , Escher, Stefan Andersson, Chakravarti, Aravinda , Ehret, Georg , Li, Man , Prineas, Ronald J. , Franco, Oscar H. , Lumley, Thomas, Dumas, Florence , McKnight, Barbara, Rotter, Jerome I. , Heckbert, Susan R. , O’Donnell, Christopher J., VanDenburgh, Martin, Uitterlinden, André G. , Hofman, Albert , Stricker, Bruno H. , Bakker, Paul I. W. de , Franks, Paul W. , Jansson, Jan‐Håkan , Asselbergs, Folkert W. , Maleszewski, Joseph J. , Tfelt‐Hansen, Jacob , Kolodgie, Frank D. , Wilde, Arthur A.M. , Bezzina, Connie R. , Eijgelsheim, Mark, Rioux, John D. , Jouven, Xavier , Arking, Dan E. , Sotoodehnia, Nona , Tanck, Michael , Tfelt-Hansen, Jacob , Rotter, Jerome I , Brody, Jennifer A , Bezzina, Connie R , Mitchell, Rebecca N, Meitinger, Thomas , Mak, Angel C. Y. , Pulit, Sara L. , Zhao, Xiaoqing , Havulinna, Aki Samuli , Coresh, Josef , Kwok, Pui–Yan , Lemaître, Rozenn N. , Hwang, Shih‐Jen , Tardif, Jean‐Claude , Halushka, Marc K. , Engstrøm, Thomas , Salomaa, Veikko , Virmani, Renu , Tan, Hanno L. , Kääb, Stefan , Psaty, Bruce M. , Siscovick, David S. , Rioux, John D , Albert, Christine M.

Mayo Clinic

European Heart Journal | July 20, 2018 | Volume: 39 | Issue: 44 | Pages: 3961-3969

10.1093/eurheartj/ehy474 | PMID 30169657 Get It

Effective nerve cell modulation by electrical stimulation of carbon nanotube embedded conductive polymeric scaffolds
Zhou, Zifei , Liu, Xifeng , Park, Sungjo , Lu, Lichun , Wu, Wei , Miller, Alan Lee , Terzic, André

Mayo Clinic

Biomaterials Science | July 18, 2018 | Volume: 6 | Issue: 9 | Pages: 2375-2385

10.1039/c8bm00553b | PMID 30019709 Get It

Biomimetic biomaterials require good biocompatibility and bioactivity to serve as appropriate scaffolds for tissue engineering applications.
The murine dialysis fistula model exhibits a senescence phenotype: pathobiological mechanisms and therapeutic potential
Nath, Karl A. , O’Brien, Daniel R. , Croatt, Anthony J., Grande, Joseph P. , Ackerman, Allan W., Nath, Meryl C. , Kirkland, James L. , Katušić, Zvonimir S. , Yamada, Satsuki , Tchkonia, Tamara, Terzic, André , Tchkonia, Tamar

Mayo Clinic

American Journal of Physiology-Renal Physiology | July 18, 2018 | Volume: 315 | Issue: 5 | Pages: F1493-F1499

10.1152/ajprenal.00308.2018 | PMID 30019935 Get It

There is no therapy that promotes maturation and functionality of a dialysis arteriovenous fistula (AVF). The search for such therapies largely relies on evaluation of vascular responses and putative therapies in experimental AVFs. We studied an AVF in mice with chronic kidney disease (CKD). We demonstrate numerous stressors in the vein of the AVF-CKD group, including pathological shear, mitogenic, inflammatory, and hypoxia-reoxygenation stress. Because stress promotes premature senescence, we examined whether senescence is induced in the vein of the AVF-CKD model. We demonstrate a senescence phenotype in the AVF-CKD model, as indicated by increased expression of p16Ink4a, p21Cip1, and p53 and expected changes for certain senescence-associated microRNAs. RNA-sequencing analysis demonstrated differential expression of ~10,000 genes, including upregulation of proinflammatory and proliferative genes, in the vein of the AVF-CKD group. The vein in the AVF-CKD group exhibited telomere erosion and increased senescence-associated β-galactosidase activity and staining. Senescence was induced in the artery of the AVF-CKD group and in the vein of the AVF without CKD. Finally, given the rapidly rising clinical interest in senolytics, we provide proof of concept of senolytics as a therapeutic approach by demonstrating that senolytics decrease p16Ink4a expression in the AVF-CKD model. This study introduces a novel concept underlying the basis for maturational and functional failure in human dialysis AVFs and identifies a new target for senolytic therapy.
Exome Chip Analysis Identifies Low-Frequency and Rare Variants in MRPL38 for White Matter Hyperintensities on Brain Magnetic Resonance Imaging
Jian, Xueqiu , Satizábal, Claudia L. , Smith, Albert V. , Wittfeld, Katharina , Bis, Joshua C. , Smith, Jennifer A. , Hofer, Edith , Mishra, Aniket , Adams, Hieab H.H. , Li, Shuo , Teumer, Alexander , Zhao, Wei , Saba, Yasaman , Yanek, Lisa R. , Chauhan, Ganesh , Buchem, Mark A. van , Royle, Natalie A., Niessen, Wiro J. , Windham, B. Gwen , DeStefano, Anita L. , Habes, Mohamad , Heckbert, Susan R. , Palmer, Nicholette D., Lewis, Cora E. , Eiríksdóttir, Guðný , Maillard, Pauline , Mathias, Rasika A. , Divers, Jasmin, Beiser, Alexa S., Langner, Sönke , Rice, Kenneth , Bastin, Mark E. , Starr, John M. , Sidney, Stephen , Risacher, Shannon L. , Uitterlinden, André G. , Guðnason, Vilmundur , Rotter, Jerome I. , Schreiner, Pamela J. , Boerwinkle, Eric , Duijn, Cornelia M. van , Sarnowski, Bettina von , Gottesman, Rebecca F., Levy, Daniel , Sigurðsson, Sigurður , Vernooij, Meike W. , Schmidt, Reinhold, Wardlaw, Joanna M. , Mosley, Thomas H. , DeCarli, Charles , Bowden, Donald W. , Becker, Diane M. , Deary, Ian J. , Schmidt, Helena , Kardia, Sharon L. R., Debette, Stéphanie , Longstreth, W.T. , Seshadri, Sudha , Launer, Lenore J. , Fornage, Myriam , Group, for the neuroCHARGE Working, Dichgans, Martin , Rice, Kenneth , Palmer, Nicholette D. , DeCarli, Charles , Turner, Stephen T. , Dichgans, Martin , Wardlaw, Joanna Marguerite , Smith, Jennifer A , Adams, Hieab H H , Satizabal, Claudia L , Seshadri, Sudha , Bastin, Mark E , Teumer, Alexander , van Duijn, Cornelia M , Debette, Stephanie , Smith, Albert V , Palmer, Nicholette D , Rotter, Jerome I , Mathias, Rasika A , Rice, Ken , Levy, Daniel , Hsu, Fang‐Chi , Nho, Kwangsik T. , Hagenaars, Saskia P. , Nyquist, Paul , Freedman, Barry I. , Cushman, Mary , Bryan, Robert Nick , Homuth, Georg , Hernández, Maria del Carmen Valdés , Divers, Jasmin , Yang, Qiong , Maldjian, Joseph A. , Nauck, Matthias A. , Mazoyer, Bernard , Psaty, Bruce M. , Saykin, Andrew J. , Ikram, M. Arfan , Grabe, Hans Jörgen , Group, for the neuroCHARGE Working, Maillard, Pauline

Mayo Clinic

Stroke | July 12, 2018 | Volume: 49 | Issue: 8 | Pages: 1812-1819

10.1161/strokeaha.118.020689 | PMID 30002152 Get It

Background and Purpose— White matter hyperintensities (WMH) on brain magnetic resonance imaging are typical signs of cerebral small vessel disease and may indicate various preclinical, age-related neurological disorders, such as stroke. Though WMH are highly heritable, known common variants explain a small proportion of the WMH variance. The contribution of low-frequency/rare coding variants to WMH burden has not been explored. Methods— In the discovery sample we recruited 20 719 stroke/dementia-free adults from 13 population-based cohort studies within the Cohorts for Heart and Aging Research in Genomic Epidemiology consortium, among which 17 790 were of European ancestry and 2929 of African ancestry. We genotyped these participants at ≈250 000 mostly exonic variants with Illumina HumanExome BeadChip arrays. We performed ethnicity-specific linear regression on rank-normalized WMH in each study separately, which were then combined in meta-analyses to test for association with single variants and genes aggregating the effects of putatively functional low-frequency/rare variants. We then sought replication of the top findings in 1192 adults (European ancestry) with whole exome/genome sequencing data from 2 independent studies. Results— At 17q25, we confirmed the association of multiple common variants in TRIM65 , FBF1 , and ACOX1 ( P <6×10 −7 ). We also identified a novel association with 2 low-frequency nonsynonymous variants in MRPL38 (lead, rs34136221; P EA =4.5×10 −8 ) partially independent of known common signal ( P EA(conditional) =1.4×10 −3 ). We further identified a locus at 2q33 containing common variants in NBEAL1 , CARF , and WDR12 (lead, rs2351524; P all =1.9×10 −10 ). Although our novel findings were not replicated because of limited power and possible differences in study design, meta-analysis of the discovery and replication samples yielded stronger association for the 2 low-frequency MRPL38 variants ( P rs34136221 =2.8×10 −8 ). Conclusions— Both common and low-frequency/rare functional variants influence WMH. Larger replication and experimental follow-up are essential to confirm our findings and uncover the biological causal mechanisms of age-related WMH.
Genetic variants in FCGR2A and FCGR3A and disease-free survival in patients with HER2 positive breast cancer treated with trastuzumab in the SUCCESS A trial
Wunderle, Marius , Rack, Brigitte , Häberle, Lothar , Lux, MP, Cunningham, JM, Rübner, Matthias, Schneeweiß, Andreas , Tesch, Hans , Heinrich, G. , Rezai, Mahdi , Beckmann, MW, Janni, Wolfgang , Weinshilboum, RM, Wang, L, Fasching, PA, Hein, Alexander , Li, Lei , Ekici, Arif B. , Reis, André , Blohmer, Jens‐Uwe , Fehm, Tanja

Mayo Clinic

Senologie - Zeitschrift für Mammadiagnostik und -therapie | July 5, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0038-1651824 Get It

Epithelial‐to‐mesenchymal transition and cancer stem cells contribute to breast cancer heterogeneity
Hong, Deli , Fritz, Andrew J. , Zaidi, Sayyed K. , Wijnen, André J. van , Nickerson, Jeffrey A. , Imbalzano, Anthony N. , Lian, Jane B. , Stein, Janet L. , Stein, Gary S. , van Wijnen, Andre J , Stein, Gary S

Mayo Clinic

Journal of Cellular Physiology | July 3, 2018 | Volume: 233 | Issue: 12 | Pages: 9136-9144

10.1002/jcp.26847 | PMID 29968906 Get It

Breast cancer is the most common cancer in women, and accounts for ~30% of new cancer cases and 15% of cancer‐related deaths. Tumor relapse and metastasis are primary factors contributing to breast cancer‐related deaths. Therefore, the challenge for breast cancer treatment is to sustain remission. A driving force behind tumor relapse is breast cancer heterogeneity (both intertumor, between different patients, and intratumor, within the same tumor). Understanding breast cancer heterogeneity is necessary to develop preventive interventions and targeted therapies. A recently emerging concept is that intratumor heterogeneity is driven by cancer stem cells (CSCs) that are capable of giving rise to a multitude of different cells within a tumor. Studies have highlighted linkage of CSC formation with epithelial‐to‐mesenchymal transition (EMT). In this review, we summarize the current understanding of breast cancer heterogeneity, links between EMT and CSCs, regulation of EMT by Runx transcription factors, and potential therapeutic strategies targeting these processes.
Mesenchymal Stem Cell-Derived Extracellular Vesicles Improve the Renal Microvasculature in Metabolic Renovascular Disease in Swine
Eirin, Alfonso , Zhu, Xiang-Yang, Jonnada, Sreela, Wijnen, André J. van , Lerman, Lilach O. , van Wijnen, Andre J , Eirin, Alfonso , Lerman, Amir

Mayo Clinic

Cell Transplantation | June 29, 2018 | Volume: 27 | Issue: 7 | Pages: 1080-1095

10.1177/0963689718780942 | PMID 29954220 Get It

Background: Extracellular vesicles (EVs) released from mesenchymal stem/stromal cells (MSCs) mediate their paracrine effect, but their efficacy to protect the microcirculation of the kidney is unknown. Using a novel swine model of unilateral renovascular disease (RVD) complicated by metabolic syndrome (MetS), we tested the hypothesis that EVs would attenuate renal microvascular loss. Methods: Four groups of pigs ( n = 7 each) were studied after 16 weeks of diet-induced MetS and RVD (MetS+RVD), MetS+RVD treated 4 weeks earlier with a single intra-renal delivery of EVs harvested from autologous adipose tissue-derived MSCs, and Lean and MetS Sham controls. Stenotic-kidney renal blood flow (RBF) and glomerular filtration rate (GFR) were measured in-vivo (fast CT), whereas EV characteristics, renal microvascular architecture (micro-CT), and injury pathways were studied ex-vivo. Results: mRNA sequencing and proteomic analysis revealed that EVs are packed with several pro-angiogenic genes and proteins, such as vascular endothelial growth factor. Labeled EVs were detected in the stenotic kidney 4 weeks after injection internalized by tubular and endothelial cells. EVs restored renal expression of angiogenic factors and improved cortical microvascular and peritubular capillary density. Renal apoptosis, oxidative stress, tubular injury, and fibrosis were also attenuated in EV-treated pigs. RBF and GFR decreased in MetS+RVD compared with MetS, but normalized in MetS+RVD+EVs. Conclusions: Intra-renal delivery of MSC-derived EVs bearing pro-angiogenic properties restored the renal microcirculation and in turn hemodynamics and function in chronic experimental MetS+RVD. Our study suggests a novel therapeutic potential for MSC-derived EVs in restoring renal hemodynamics in experimental MetS+RVD.
Follistatin‐like protein 1 induction of matrix metalloproteinase 1, 3 and 13 gene expression in rheumatoid arthritis synoviocytes requires MAPK, JAK/STAT3 and NF‐κB pathways
Ni, Su , Li, Chenkai , Xu, Nanwei , Wang, Wei , Wang, Yuji , Wijnen, André J. van , van Wijnen, Andre J , Liu, Xi , Chen, Wenyang

Mayo Clinic

Journal of Cellular Physiology | June 22, 2018 | Volume: 234 | Issue: 1 | Pages: 454-463

10.1002/jcp.26580 | PMID 29932210 Get It

Elevated levels of follistatin‐like protein 1 (FSTL1) have been found both in mouse models for human rheumatoid arthritis (RA) and collagen‐induced arthritis (CIA). In this study, we elucidated the potential mechanisms by which FSTL1 contributes to the pathogenesis of RA. Fibroblast‐like synoviocytes (FLSs) were established from synovial tissues of RA patients and stimulated with human recombinant FSTL1. Protein and mRNA expression levels of select matrix metalloproteinases (i.e., MMP1, MMP3, MMP13) in FLS were measured by, respectively, real‐time RT‐qPCR and ELISA. Activation of MAPK and other pathways that affect MMPs were evaluated by Western blotting. We also compared concentrations of MMPs in plasma in RA patients versus healthy controls (HC). Expression levels of MMP1, MMP3, and MMP13 were clearly stimulated by FSTL1 in vitro. FSTL1 activated the inflammation‐related NF‐κB signaling pathway, as well as all three mitogen‐activated protein kinase (MAPK) pathways and the JAK/STAT3 pathway. Moreover, select chemical inhibitors that target p38 (SB203580), Erk1/2 (SP600125), JNK (SCH772984), STAT3 (AG490), and NF‐κB (BAY 11–7082) significantly attenuated MMP expression. Inhibition of Toll‐like receptor 4 by compound TAK‐242 significantly abolished those effects of FSTL1. Importantly, elevated plasma concentrations of MMP3 were found to correlate with plasma FSTL1 levels in RA patients. These findings suggest that FSTL1 accelerates RA progression by activating MAPK, JAK/STAT3, and NF‐κB pathways to enhance secretion of different MMPs and this enhancement is via TLR4. Targeting FSTL1 may provide a promising pharmacological drug therapy to ameliorate RA symptoms and perhaps reverse disease progression.
Expression of the ectodomain‐releasing protease ADAM17 is directly regulated by the osteosarcoma and bone‐related transcription factor RUNX2
Araya, Héctor, Sepúlveda, Hugo , Lizama, Carlos O. , Vega, Oscar A., Jerez, Sofía , Briceño, Pedro, Thaler, Roman, Riester, Scott M. , Antonelli, Marcelo , Salazar‐Onfray, Flavio , Montecino, Martı́n , Charbonneau, Martine , Dubois, Claire M. , Stein, Gary S., Wijnen, André J. van , Galindo, Mario , van Wijnen, Andre J , Galindo, Mario A , Rodríguez, Juan Pablo , Moreno, Ricardo D. , Dubois, Claire M

Mayo Clinic

Journal of Cellular Biochemistry | June 20, 2018 | Volume: 119 | Issue: 10 | Pages: 8204-8219

10.1002/jcb.26832 | PMID 29923217 Get It

AbstractOsteoblast differentiation is controlled by transcription factor RUNX2 which temporally activates or represses several bone‐related genes, including those encoding extracellular matrix proteins or factors that control cell‐cell, and cell‐matrix interactions. Cell‐cell communication in the many skeletal pericellular micro‐niches is critical for bone development and involves paracrine secretion of growth factors and morphogens. This paracrine signaling is in part regulated by “A Disintegrin And Metalloproteinase” (ADAM) proteins. These cell membrane‐associated metalloproteinases support proteolytic release (“shedding”) of protein ectodomains residing at the cell surface. We analyzed microarray and RNA‐sequencing data for Adam genes and show that Adam17, Adam10, and Adam9 are stimulated during BMP2 mediated induction of osteogenic differentiation and are robustly expressed in human osteoblastic cells. ADAM17, which was initially identified as a tumor necrosis factor alpha (TNFα) converting enzyme also called (TACE), regulates TNFα‐signaling pathway, which inhibits osteoblast differentiation. We demonstrate that Adam17 expression is suppressed by RUNX2 during osteoblast differentiation through the proximal Adam17 promoter region (−0.4 kb) containing two functional RUNX2 binding motifs. Adam17 downregulation during osteoblast differentiation is paralleled by increased RUNX2 expression, cytoplasmic‐nuclear translocation and enhanced binding to the Adam17 proximal promoter. Forced expression of Adam17 reduces Runx2 and Alpl expression, indicating that Adam17 may negatively modulate osteoblast differentiation. These findings suggest a novel regulatory mechanism involving a reciprocal Runx2‐Adam17 negative feedback loop to regulate progression through osteoblast differentiation. Our results suggest that RUNX2 may control paracrine signaling through regulation of ectodomain shedding at the cell surface of osteoblasts by directly suppressing Adam17 expression.